Robeco Institutional Asset Management B.V. Abb Vie Inc. Transaction History

Robeco Institutional Asset Management B.V.

$60.3 Billion
Q2 2025

A detailed history of Robeco Institutional Asset Management B.V. transactions in Abb Vie Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 3,162,653 shares of ABBV stock, worth $602 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

3,162,653

Previous 3,876,732 18.42%

Holding current value

$602 Million

Previous $812 Million 27.73%

% of portfolio

0.97%

Previous 1.61%

45 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	SELL	$170.16 - $206.27 $122 Million - $147 Million	-714,079 Reduced 18.42%	3,162,653 $587 Million
Q1 2025 Apr 23, 2025	BUY	$169.2 - $216.66 $33.5 Million - $42.9 Million	198,049 Added 5.38%	3,876,732 $812 Million
Q4 2024 Jan 22, 2025	BUY	$164.99 - $203.87 $18.6 Million - $23 Million	112,925 Added 3.17%	3,678,683 $654 Million
Q3 2024 Oct 29, 2024	BUY	$163.84 - $199.33 $43 Million - $52.3 Million	262,316 Added 7.94%	3,565,758 $704 Million
Q2 2024 Jul 22, 2024	BUY	$154.79 - $180.76 $4.54 Million - $5.3 Million	29,346 Added 0.9%	3,303,442 $567 Million
Q1 2024 Apr 24, 2024	BUY	$159.82 - $182.1 $176 Million - $201 Million	1,101,089 Added 50.67%	3,274,096 $596 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $113 Million - $127 Million	821,803 Added 60.82%	2,173,007 $337 Million
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $24.9 Million - $28.1 Million	-181,086 Reduced 11.82%	1,351,204 $2.17 Billion
Q3 2023 Oct 23, 2023	BUY	$133.59 - $154.65 $2.72 Million - $3.14 Million	20,333 Added 1.34%	1,532,290 $228 Million
Q2 2023 Jul 24, 2023	BUY	$132.51 - $164.9 $1.7 Million - $2.12 Million	12,832 Added 0.86%	1,511,957 $204 Million
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $31.6 Million - $36.4 Million	-218,642 Reduced 12.73%	1,499,125 $239 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $46.5 Million - $55.8 Million	-336,458 Reduced 16.38%	1,717,767 $278 Million
Q3 2022 Dec 01, 2022	SELL	$134.21 - $153.93 $23 Million - $26.4 Million	-171,708 Reduced 7.71%	2,054,225 $276 Million
Q3 2022 Oct 26, 2022	SELL	$134.21 - $153.93 $23 Million - $26.4 Million	-171,708 Reduced 7.71%	2,054,225 $276 Million
Q2 2022 Dec 01, 2022	BUY	$137.62 - $174.96 $39.8 Million - $50.6 Million	289,108 Added 14.93%	2,225,933 $341 Million
Q2 2022 Jul 27, 2022	BUY	$137.62 - $174.96 $39.8 Million - $50.6 Million	289,108 Added 14.93%	2,225,933 $341 Million
Q1 2022 Dec 01, 2022	BUY	$131.98 - $163.75 $117 Million - $145 Million	887,064 Added 84.5%	1,936,825 $314 Million
Q1 2022 Apr 26, 2022	BUY	$131.98 - $163.75 $117 Million - $145 Million	887,064 Added 84.5%	1,936,825 $314 Million
Q4 2021 Dec 01, 2022	BUY	$107.43 - $135.93 $33 Million - $41.8 Million	307,472 Added 41.42%	1,049,761 $142 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $33 Million - $41.8 Million	307,472 Added 41.42%	1,049,761 $142 Million
Q3 2021 Dec 01, 2022	BUY	$106.4 - $120.78 $70,756 - $80,318	665 Added 0.09%	742,289 $80.1 Million
Q3 2021 Oct 20, 2021	BUY	$106.4 - $120.78 $70,756 - $80,318	665 Added 0.09%	742,289 $80.1 Million
Q2 2021 Dec 01, 2022	SELL	$105.21 - $117.21 $83.8 Million - $93.3 Million	-796,348 Reduced 51.78%	741,624 $83.5 Million
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $83.8 Million - $93.3 Million	-796,348 Reduced 51.78%	741,624 $83.5 Million
Q1 2021 Dec 01, 2022	SELL	$102.3 - $112.62 $52.8 Million - $58.1 Million	-516,253 Reduced 25.13%	1,537,972 $166 Million
Q1 2021 Apr 23, 2021	SELL	$102.3 - $112.62 $38.6 Million - $42.5 Million	-377,401 Reduced 19.7%	1,537,972 $166 Million
Q4 2020 Dec 01, 2022	SELL	$80.49 - $108.67 $11.2 Million - $15.1 Million	-138,852 Reduced 6.76%	1,915,373 $205 Million
Q4 2020 Jan 28, 2021	SELL	$80.49 - $108.67 $71 Million - $95.8 Million	-881,488 Reduced 31.52%	1,915,373 $205 Million
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $2.02 Million - $2.38 Million	-23,568 Reduced 0.84%	2,796,861 $245 Million
Q2 2020 Jul 20, 2020	BUY	$73.37 - $98.18 $4.64 Million - $6.21 Million	63,217 Added 2.29%	2,820,429 $277 Million
Q1 2020 Apr 30, 2020	SELL	$64.5 - $97.79 $3.9 Million - $5.92 Million	-60,495 Reduced 2.15%	2,757,212 $210 Million
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $7.08 Million - $8.86 Million	-98,168 Reduced 3.37%	2,817,707 $249 Million
Q3 2019 Oct 17, 2019	BUY	$62.98 - $75.72 $22.1 Million - $26.6 Million	350,870 Added 13.68%	2,915,875 $221 Million
Q2 2019 Jul 19, 2019	BUY	$65.7 - $83.98 $64.4 Million - $82.3 Million	979,638 Added 61.79%	2,565,005 $187 Million
Q1 2019 May 02, 2019	BUY	$77.14 - $90.79 $21.5 Million - $25.3 Million	278,226 Added 21.29%	1,585,367 $128 Million
Q4 2018 Feb 08, 2019	SELL	$77.85 - $96.01 $8.24 Million - $10.2 Million	-105,891 Reduced 7.49%	1,307,141 $120 Million
Q3 2018 Oct 31, 2018	BUY	$88.91 - $98.84 $126 Million - $140 Million	1,413,032 New	1,413,032 $134 Million
Q3 2018 Oct 25, 2018	SELL	$88.91 - $98.84 $102 Million - $113 Million	-1,143,797 Closed	0 $0
Q2 2018 Jan 19, 2021	BUY	$89.78 - $106.23 $103 Million - $122 Million	1,143,797 New	1,143,797 $106 Million
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $100 Million - $119 Million	-1,115,661 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $5.38 Million - $7.2 Million	-58,444 Reduced 4.98%	1,115,661 $106 Million
Q4 2017 Jan 25, 2018	BUY	$89.56 - $98.21 $22.8 Million - $25 Million	254,587 Added 27.69%	1,174,105 $114 Million
Q3 2017 Oct 17, 2017	BUY	$69.85 - $89.22 $1.56 Million - $1.99 Million	22,264 Added 2.48%	919,518 $81.7 Million
Q2 2017 Aug 08, 2017	SELL	N/A	-66,552 Reduced 6.91%	897,254 $65.1 Million
Q1 2017 Jan 19, 2021	BUY	N/A	963,806	963,806 $62.8 Million

Others Institutions Holding ABBV

# of Institutions

4,252

Shares Held

1.27B

Call Options Held

16.8M

Put Options Held

15.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $336B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account

Robeco Institutional Asset Management B.V. Abb Vie Inc. Transaction History